Dr Kyi Kyi Tha joined the Jeffrey Cheah School of Medicine & Health Sciences, Monash University Malaysia on 8th February 2011 as a Senior Lecturer in Pharmacology, Department of Biomedical Sciences. She graduated with M.B.,B.S. from University of Medicine (2) Yangon, Myanmar in 1990.

Lecturer, Department of Pharmacology, University of Medicine (2) Yangon, Myanmar. Research Officer in Clinical Research Unit, Defence Services General Hospital, Yangon, Myanmar. House Officer in Medicine, Surgery, Obstetric & Gynaecology and Paediatrics at the North Okkalapa General Hospital, Ministry of Health, Yangon, Myanmar.

Kyi THA, Senior lecturer | Cited by 290 | of Monash University (Australia), Melbourne | Read 44 publications | Contact Kyi THA

2nd Forum on Hematological Malignancies in Children, St. Jude-Viva Forum in …

Pro-vice Chancellor (PVC) Award for Excellence in Education Innovation (2020) Bachelor of Medical Science (Honours) - Representing the TOP innovative program (Team leader: Dr. Kyi Kyi Tha)

Kyi Kyi Tha via Scopus - Elsevier α-ketoglutaric acid-modified carbonate apatite enhances cellular uptake and cytotoxicity of a raf-kinase inhibitor in breast cancer cells through inhibition of MAPK and PI-3 kinase pathways

2019年1月3日 · We incorporated AZ628 into CA and also modified it with α-ketoglutaric acid (α-KA) for reducing particle growth kinetics and increasing total surface area to improve the delivery of AZ628 by enhancing cellular uptake by breast cancer cells.

2018年5月26日 · RNA Interference (RNAi) has brought revolutionary transformations in cancer management in the past two decades. RNAi-based therapeutics including siRNA and shRNA have immense scope to silence the expression of mutant cancer genes specifically in a therapeutic context.